ScholarIQanswers from OpenAlex
213 Selpercatinib in RET Fusion Lung Adenocarcinoma
PaperCitations, authors & open-access status
213 Selpercatinib in RET Fusion Lung Adenocarcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does 213 Selpercatinib in RET Fusion Lung Adenocarcinoma have?
ScholarIQcitation count
213 Selpercatinib in RET Fusion Lung Adenocarcinoma has 0 citations in the OpenAlex counts ScholarIQ stores.
When was 213 Selpercatinib in RET Fusion Lung Adenocarcinoma published?
ScholarIQyear
213 Selpercatinib in RET Fusion Lung Adenocarcinoma has 2024 year in the ScholarIQ index.
What is the open-access status of 213 Selpercatinib in RET Fusion Lung Adenocarcinoma?
ScholarIQoa status
213 Selpercatinib in RET Fusion Lung Adenocarcinoma has closed oa status in the ScholarIQ index.
What is the DOI of 213 Selpercatinib in RET Fusion Lung Adenocarcinoma?
ScholarIQdoi
The DOI for 213 Selpercatinib in RET Fusion Lung Adenocarcinoma is on the source record.
What is the OpenAlex record for 213 Selpercatinib in RET Fusion Lung Adenocarcinoma?
ScholarIQopenalex
The OpenAlex for 213 Selpercatinib in RET Fusion Lung Adenocarcinoma is on the source record.